| Financial Year |
March 31 2023 |
| Monetary Funds |
9,022,652,827.74 |
| Held-for-trading Financial Assets |
100,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,521,324,494.18 |
| Advances to Suppliers |
41,551,676.82 |
| Other Receivables |
20,604,342.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
843,882,659.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,019,462.48 |
| Total Current Assets |
11,654,235,463.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
218,445,871.92 |
| Investment Properties |
467,832,610.35 |
| Fixed Assetes |
22,837,010,958.19 |
| Under-construction Projects |
3,354,199,832.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,646,034,623.78 |
| R&D expenses |
-- |
| Goodwill |
98,318,993.84 |
| Long-Term Deferred and Prepaid Expenses |
6,391,177.76 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
349,969,666.85 |
| Sub-Total of Non-Current Assets |
28,978,203,735.03 |
| Total Assets |
40,632,439,198.66 |
| Short-Term Loans |
2,994,493,009.74 |
| Trading Financial liabilities |
-- |
| Notes Payable |
977,628,328.57 |
| Accounts Payable |
2,274,895,502.91 |
| Accounts Received In Advance |
2,187,778.12 |
| Employee Compensation Payable |
43,087,108.71 |
| Taxes Payable |
19,340,435.06 |
| Interest Payable |
-- |
| Dividend Payable |
1,948,720.00 |
| Other payables |
105,819,097.74 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,970,747,229.33 |
| Other Current Liabilities |
1,007,079.06 |
| Sub-Total of Current Liabilities |
9,399,183,992.27 |
| Long-term Loans |
11,323,610,531.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
7,703,851.14 |
| Deferred Income Tax Liabilities |
12,822,656.52 |
| Other Non-Current Liabilities |
210,000,000.00 |
| Sub-Total of Non-Current Liabilities |
11,903,777,302.61 |
| Total Liabilities |
21,302,961,294.88 |
| Paid-In Capital(Or Share Stock) |
3,588,389,732.00 |
| Capital Surplus |
20,447,913,299.25 |
| Surplus Reserve |
230,140,908.12 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,102,968,315.01 |
| Minority Stockholder's Interest |
166,002,279.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,163,475,624.36 |
| Owner's Equity（Stockholder's Equity） |
19,329,477,903.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
40,632,439,198.66 |
